Cresset Discovery Services Enters Collaboration With the University of Newcastle, Australia, To Repurpose Therapeutics Against Oncology Targets
CAMBRIDGE, UK / AGILITYPR.NEWS / September 14, 2021 / Cresset Discovery Services, provider of contract research services for early phase of drug discovery, has announced it will collaborate with the University of Newcastle, Australia to focus on drug reprofiling against oncology targets. The work will build on research led by award-winning molecular biologist, Associate Professor Nikola Bowden.
Nikola is co-Director of the Centre for Drug Repurposing and Medicines Research, and leads the DNA repair group. The overall aim of her research is to deliver personalized diagnosis and treatment to cancer patients, with a focus on DNA repair and drug repurposing in melanoma and ovarian cancer.
Repurposing existing drugs offers a promising solution to cancer patients in need of more immediate treatment. Having prior knowledge of a drug’s safety, dosing and side effects can significantly shorten research and development timelines.
“We’re excited to collaborate with Nikola and her team on this project. The intelligent computational approaches that we specialize in are ideally placed to identify which existing drugs are viable against new targets,” says Dr Martin Slater, Director of Consulting Services at Cresset Discovery Services.
“Using existing drugs as a starting point for new therapies can provide patients with access to critical treatment in a quick and cost-effective manner,” says Associate Professor Nikola Bowden. “We’re looking forward to engaging the in silico solutions and drug discovery expertise offered by Cresset to advance our research in this area.”
About Us
Cresset
Chemists in the world’s leading research organizations use Cresset software and discovery services to discover, design and optimize the best small molecules. Our patented software and expert scientists offer unrivalled insight into protein-ligand systems, enabling chemists to accelerate their research in industry sectors including pharmaceuticals, agrochemicals, fine chemicals and flavors and fragrances. www.cresset-group.com
University of Newcastle, Australia
Guided by our values of equity, excellence, sustainability and engagement, the University of Newcastle has built a strong reputation as a world-leading university making an impact within our own regions, in Australia and across the globe. We are ranked in the top 200 of the world’s universities by QS World University Rankings.
Our research is world-class and diverse. Our degree programs are internationally- recognised and our partnerships and collaborations drive meaningful innovation. Our alumni are leaders and our students are preparing to make a difference in the world.
Across our campuses in Newcastle, the Central Coast, Sydney and Singapore, the University of Newcastle enrols more than 37,000 students from diverse backgrounds, with a focus on equity and developing our next generation of socially- oriented leaders, entrepreneurs and innovators.
Cresset BioMolecular Discovery Limited,
New Cambridge House, Bassingbourn Road, Cambridgeshire, SG8 0SS, UK
Tel +44 (0)1223 858890 Fax +44 (0)1223 853667 www.cresset-group.com
Registered in England & Wales No. 4151475
VAT Registration No. GB 780 3418 32
Chemists in the world’s leading research organizations use Cresset software and discovery services to discover, design and optimize the best small molecules. Our patented software and expert scientists offer unrivalled insight into protein-ligand systems, enabling chemists to accelerate their research in industry sectors including pharmaceuticals, agrochemicals, fine chemicals and flavors and fragrances. www.cresset-group.com
University of Newcastle, Australia
Guided by our values of equity, excellence, sustainability and engagement, the University of Newcastle has built a strong reputation as a world-leading university making an impact within our own regions, in Australia and across the globe. We are ranked in the top 200 of the world’s universities by QS World University Rankings.
Our research is world-class and diverse. Our degree programs are internationally- recognised and our partnerships and collaborations drive meaningful innovation. Our alumni are leaders and our students are preparing to make a difference in the world.
Across our campuses in Newcastle, the Central Coast, Sydney and Singapore, the University of Newcastle enrols more than 37,000 students from diverse backgrounds, with a focus on equity and developing our next generation of socially- oriented leaders, entrepreneurs and innovators.
Cresset BioMolecular Discovery Limited,
New Cambridge House, Bassingbourn Road, Cambridgeshire, SG8 0SS, UK
Tel +44 (0)1223 858890 Fax +44 (0)1223 853667 www.cresset-group.com
Registered in England & Wales No. 4151475
VAT Registration No. GB 780 3418 32
Contacts
Associate Professor Nikola Bowden
Research Fellow
nikola.bowden@newcastle.edu.auUniversity of Newcastle